All Stories

  1. Preclinical evaluation of a MAGE-A3 vaccination utilizing the oncolytic Maraba virus currently in first-in-human trials

    Article • OncoImmunology, September 2018, Taylor & Francis

    Dr Sergio A Acuna, Dr Jonathan G Pol, Mathieu Crupi, Dr Brian Lichty, Robin Parsons

  2. Human Coronavirus OC43 Nucleocapsid Protein Binds MicroRNA 9 and Potentiates NF- B Activation

    Article • Journal of Virology, October 2013, ASM Journals

    Dr Brian Lichty

  3. Oncolytic viruses: a step into cancer immunotherapy.

    Article • Virus Adaptation and Treatment, December 2011, Taylor & Francis

    Dr Jonathan G Pol, Dr Brian Lichty